QUOTE AND NEWS
Motley Fool  Jun 15  Comment 
Trial results for blood cancer drugs in TG Therapeutics' pipeline could one day change how patients with advanced disease are treated.
Motley Fool  Jun 13  Comment 
After presentations at the annual American Society of Clinical Oncology conference this week sent shares higher, investors in bluebird bio, TG Therapeutics, and Loxo Oncology are cheering.
MarketWatch  Jun 5  Comment 
TG Therapeutics Inc. shares rose 3.7% in morning trade Monday after the company said a late-stage clinical trial for its TG-1101 with AbbVie and Johnson & Johnson's Imbruvica had positive results. The drug combination was tested in patients...
Motley Fool  Jun 2  Comment 
Investors are looking forward to the biotech's presentation at the American Society of Clinical Oncology (ASCO) meeting.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki